Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Catabasis Pharmaceuticals begins Phase lll DMD trial of edasalonexent

Histopathology of gastrocnemius muscle from a patient who died of Duchenne type pseudohypertrophic muscular dystrophy. Credit: Dr Edwin P Ewing, Jr.



Go Top